Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Evaluate the Safety of Twice Daily Oral Carvedilol
This study has been completed.
Study NCT00129363   Information provided by Shaddy, Robert, M.D.

First Received on August 8, 2005.   Last Updated on December 24, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Congestive Heart Failure
Additional conditions recognized in this trial
Heart Failure
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Interventions listed in this trial
Carvedilol
Additional drug interventions recognized in this trial
Adrenergic alpha-Antagonists
Adrenergic beta-Antagonists
Natriuretic Peptide, Brain
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic alpha-1 Receptor Antagonists
Adrenergic Antagonists
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Shaddy, Robert, M.D.
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services